A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 303, Issue 2, 2012, Pages

  Hilzendeger, Aline M ^a   Morgan, Donald A ^a   Brooks, Leonard ^a   Dellsperger, David ^a   Liu, Xuebo ^a   Grobe, Justin L ^a   Rahmouni, Kamal ^a   Sigmund, Curt D ^a   Mark, Allyn L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Angiotensin II type 1a receptor deletion; Angiotensin converting enzyme; Brown adipose tissue; Captopril; Kidney; Losartan

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; BRAIN PROTEIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; LEPTIN; LOSARTAN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTERIAL PRESSURE; ARTICLE; BODY WEIGHT; BRAIN REGION; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GENOTYPE; HEMODYNAMIC MONITORING; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC NERVE; SYMPATHETIC NERVE CELL; UPREGULATION; WILD TYPE;

ADIPOSE TISSUE; ALPHA-MSH; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BODY WEIGHT; BRAIN; CAPTOPRIL; CORTICOTROPIN-RELEASING HORMONE; EATING; GENE DELETION; LEPTIN; LOSARTAN; MALE; MICE; MICE, INBRED C57BL; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 84864011880     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00974.2011     Document Type: Article

References (57)

1. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 105: 1243-1252, 2000.
2. Arakawa H, Chitravanshi VC, Sapru HN. The hypothalamic arcuate nucleus: a new site of cardiovascular action of angiotensin-(1-12) and angiotensin II. Am J Physiol Heart Circ Physiol 300: H951-H960, 2011.
3. Arnold AC, Shaltout HA, Gallagher PE, Diz DI. Leptin impairs cardiovagal baroreflex function at the level of the solitary tract nucleus. Hypertension 54: 1001-1008, 2009.
4. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287: R943-R949, 2004.
5. 1-receptor antagonism reverses the blood pressure elevation associated with dietinduced obesity. Am J Physiol Regul Integr Comp Physiol 289: R181-R186, 2005.
6. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 39: 496-501, 2002.
7. Cassis LA, English VL, Bharadwaj K, Boustany CM. Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology 145: 169-174, 2004.
8. Chen D, La Greca L, Head GA, Walther T, Mayorov DN. Blood pressure reactivity to emotional stress is reduced in AT1A-receptor knockout mice on normal, but not high salt intake. Hypertens Res 32: 559-564, 2009.
9. Considine RV, Caro JF. Leptin and the regulation of body weight. Int J Biochem Cell Biol 29: 1255-1272, 1997.
10. Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51: 439-442, 2002.
11. Davisson RL, Yang G, Beltz TG, Cassell MD, Johnson AK, Sigmund CD. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res 83: 1047-1058, 1998.
12. de Kloet AD, Krause EG, Scott KA, Foster MT, Herman JP, Sakai RR, Seeley RJ, Woods SC. Central angiotensin II has catabolic action at white and brown adipose tissue. Am J Physiol Endocrinol Metab 301: E1081-E1091, 2011.
13. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46: 2040-2043, 1997.
14. Dyer AR, Elliott P, Shipley M, Stamler R, Stamler J. Body mass index and associations of sodium and potassium with blood pressure in INTERSALT. Hypertension 23: 729-736, 1994.
15. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 79: 21-29, 2001.
16. Friedman JM. Obesity: Causes and control of excess body fat. Nature 459: 340-342, 2009.
17. Grill HJ. Distributed neural control of energy balance: contributions from hindbrain and hypothalamus. Obesity 14, Suppl 5: 216S-221S, 2006.
18. Grobe JL, Buehrer BA, Hilzendeger AM, Liu X, Davis DR, Xu D, Sigmund CD. Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice. Hypertension 57: 600-607, 2011.
19. Grobe JL, Grobe CL, Beltz TG, Westphal SG, Morgan DA, Xu D, de Lange WJ, Li H, Sakai K, Thedens DR, Cassis LA, Rahmouni K, Mark AL, Johnson AK, Sigmund CD. The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab 12: 431-442, 2010.
20. Grobe JL, Xu D, Sigmund CD. An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology (Bethesda) 23: 187-193, 2008.
21. Hall JE. The kidney, hypertension, obesity. Hypertension 41: 625-633, 2003.
22. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, Smith G, Stec DE. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem 285: 17271-17276, 2010.
23. Harlan SM, Morgan DA, Agassandian K, Guo DF, Cassell MD, Sigmund CD, Mark AL, Rahmouni K. Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation. Circ Res 108: 808-812, 2011.
24. Hausberg M, Morgan DA, Chapleau MA, Sivitz WI, Mark AL, Haynes WG. Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. J Hypertens 20: 1633-1641, 2002.
25. Hayes MR, Skibicka KP, Leichner TM, Guarnieri DJ, DiLeone RJ, Bence KK, Grill HJ. Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation. Cell Metab 11: 77-83, 2010.
26. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptormediated regional sympathetic nerve activation by leptin. J Clin Invest 100: 270-278, 1997.
27. Hilzendeger AM, Morais RL, Todiras M, Plehm R, da Costa Goncalves A., Qadri F., Araujo RC, Gross V, Nakaie CR, Casarini DE, Carmona AK, Bader M, Pesquero JB. Leptin regulates ACE activity in mice. J Mol Med 88: 899-907, 2010.
28. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, Egan GF, McKinley MJ, Rodger PD, Sinclair AJ, Wark JD, Weisinger HS, Jois M, Weisinger RS. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA 105: 6531-6536, 2008.
29. Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM. The relation of adiposity to blood pressure and development of hypertension. The Framingham Study. Ann Intern Med 67: 48-59, 1967.
30. Kouyama R, Suganami T, Nishida J, Tanaka M, Toyoda T, Kiso M, Chiwata T, Miyamoto Y, Yoshimasa Y, Fukamizu A, Horiuchi M, Hirata Y, Ogawa Y. Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 146: 3481-3489, 2005.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-delta delta C(T)] method. Methods 25: 402-408, 2001.
32. Mark AL, Agassandian K, Morgan DA, Liu X, Cassell MD, Rahmouni K. Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney. Hypertension 53: 375-380, 2009.
33. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG. Stateof-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension 33: 537-541, 1999.
34. Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 20: 1245-1250, 2002.
35. Marsh AJ, Fontes MA, Killinger S, Pawlak DB, Polson JW, Dampney RA. Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 42: 488-493, 2003.
36. McKinley MJ, Allen AM, Clevers J, Paxinos G, Mendelsohn FA. Angiotensin receptor binding in human hypothalamus: autoradiographic localization. Brain Res 420: 375-379, 1987.
37. Morimoto S, Cassell MD, Sigmund CD. Glia-and neuron-specific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference. J Biol Chem 277: 33235-33241, 2002.
38. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates (4th ed.). San Diego, CA: Academic, 1998.
39. Porter JP, Anderson JM, Robison RJ, Phillips AC. Effect of central angiotensin II on body weight gain in young rats. Brain Res 959: 20-28, 2003.
40. Porter JP, Potratz KR. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol 287: R422-R428, 2004.
41. Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani JP, Barzel B, Head GA. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 55: 862-868, 2010.
42. Rahmouni K, Fath MA, Seo S, Thedens DR, Berry CJ, Weiss R, Nishimura DY, Sheffield VC. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J Clin Invest 118: 1458-1467, 2008.
43. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci 23: 5998-6004, 2003.
44. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 39: 486-490, 2002.
45. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54: 2012-2018, 2005.
46. Santos EL, de Picoli Souza K, Guimaraes PB, Reis FC, Silva SM, Costa-Neto CM, Luz J, Pesquero JB. Effect of angiotensin converting enzyme inhibitor enalapril on body weight and composition in young rats. Int Immunopharmacol 8: 247-253, 2008.
47. Smith PM, Chambers AP, Price CJ, Ho W, Hopf C, Sharkey KA, Ferguson AV. The subfornical organ: a central nervous system site for actions of circulating leptin. Am J Physiol Regul Integr Comp Physiol 296: R512-R520, 2009.
48. Smith PM, Ferguson AV. Cardiovascular actions of leptin in the subfornical organ are abolished by diet-induced obesity. J Neuroendocrinol 24: 504-510, 2012.
49. Smith PM, Ferguson AV. Circulating signals as critical regulators of autonomic state-central roles for the subfornical organ. Am J Physiol Regul Integr Comp Physiol 299: R405-R415, 2010.
50. Stucchi P, Cano V, Ruiz-Gayo M, Fernandez-Alfonso MS. Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity. Br J Pharmacol 158: 771-778, 2009.
51. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48: 58-64, 2006.
52. Thatcher S, Yiannikouris F, Gupte M, Cassis L. The adipose reninangiotensin system: role in cardiovascular disease. Mol Cell Endocrinol 302: 111-117, 2009.
53. Wei SG, Zhang ZH, Yu Y, Felder RB. Systemically administered tempol reduces neuronal activity in paraventricular nucleus of hypothalamus and rostral ventrolateral medulla in rats. J Hypertens 27: 543-550, 2009.
54. Weisinger RS, Stanley TK, Begg DP, Weisinger HS, Spark KJ, Jois M. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiol Behav 98: 192-197, 2009.
55. Yoshida T, Semprun-Prieto L, Wainford RD, Sukhanov S, Kapusta DR, Delafontaine P. Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus. Endocrinology 153: 1411-1420, 2012.
56. Yvan-Charvet L, Massiera F, Lamande N, Ailhaud G, Teboul M, Moustaid-Moussa N, Gasc JM, Quignard-Boulange A. Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue. Endocrinology 150: 1421-1428, 2009.
57. Zorad S, Dou JT, Benicky J, Hutanu D, Tybitanclova K, Zhou J, Saavedra JM. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma. Eur J Pharmacol 552: 112-122, 2006.